Phase 3 TRIUMPH trials are expected to complete by mid-2026, with potential FDA approval in 2027
Food and Drug Administration Zepbound (tirzepatide) injection Prescribing Information and Approval History
Some research has explored GH and GLP-1 interactions in the context of metabolic syndrome, but these studies do not address the triple-agonist profile of retatrutide
Once you finish nursing, this personalized data helps your clinician choose whether semaglutide, tirzepatide, or a dual compound like GLP-Squared is most likely to deliver results for your unique biology, maximizing efficacy and minimizing side effects
211215 Recently, GLP-1 action has additionally been expanded to potential regulation of autophagy in islet beta-cells: Exendin-4 induced autophagy in INS-1E cells and isolated human islets during chronic exposure to excess nutrients, by promotion of autophagosomal-lysosomal fusion
If more Medicare beneficiaries with obesity or overweight gain access to GLP-1s based on other approved uses for these medications, that could reduce the cost of proposed legislation to lift the statutory prohibition on Medicare coverage of anti-obesity drugs